 DiePharmazie INDEX VOLUME 57 (2002) How to use this index: 1. There is a subject index and an author index 2. You may use the search function of your web-browser to find any keyword in the indexes of this document 3. The indexes give a page number, please find the respective issue in the page directory. (O = Original Article; R = Review; SC = Short Communication; A =
Accounts of Experience) Numbers refer to the first page of the article Abietane diterpenoid from Indigofera
O 714 Agave lophantha O 562 Agkistrodon halys ussuriensis O 482 Albizia adianthifolia O 705 Alkaloids, - from Triumfetta O 709 - from Consolida O 761 - from Aconitum O 427 Aloe arborescens O 834 Aloe ointments O 834 Aloe O 172 Altounyan, R.E.C. O 62 Aluminium powder O 471 Amlodipine SC 500 Amphoteric molecules, - membrane effects SC 497 Analgesia, - combination therapy O 485 - systemic O 485 Analysis, - 2-thiouracil O 393 - alkyl amines O 456 - amlodipine SC 500 - aristolochic acids O 686 - atovaquone O 465 - biotin O 316 - bromometric O 172, O 316, O 393 - BTMP O 252 - celecoxib O 619 - cetirizine O 313 - chlorzoxazone O 811 - cisparide SC 501 - flucytosine O 316 - fluvastatin O 817 - glass O 396 - hexetidine O 248 - hypericine O 178 - iodine in contrast media O 471 - iodine number O 538 - iodometric O 471 - iron O 45 - lacidipine SC 503 - levofloxacin SC 587 - methoxychalcones O 614 - methoxyflavanones O 614 - mosparide O 814 - particle size O 546 - PETN O 460 - Piper constituents O 622 - polysorbate 80 O 316 - propylthiouracil O 393 - pseudohyericine O 178 - pyridine derivatives O 250 - quercetin SC 216 - simvastatin O 817 - sorbic acid O 316 - ß-galactosidase O 176 - sulphur O 393 - tinidazole O 535 - urushiols SC 508 Anthraquinone derivatives O 399 Anthraquinone derivatives from Asphodelus O 286 Antianemics, - new O 155 Anticholinergics, -soft O 115 Anti-glaucoma agents O 108 Antihistamines, - history O 62 Antioxidants O 122, O 474, O 635 Antiplatelet therapies, - oral SC 863 Apoptosis O 323 Aristolochia sp. O 686 Aristolochic acids O 686 1-Aryl-isochromanes SC 343 Arsenic trioxide R 223 Artemisia afra SC 351 Artificial neural network SC 655 Asarum sp. O 686 Ascochital SC 510 Ascochitin O 270 Ascochital O 270 Ascorbic acid O 753 Asphodelus tenuifolius O 286 Aspilia africana O 421 Aster ageratoides O 567 Aster subspicatus O 567 Asthma bronchiale R 83 Atovaquone O 465 Atractyligenine O 374 Atropine analogues O 115 Azidothymidin-CDS R 96 Basidiomycetes, - antimutagenic activity O 416 BCS system R 291 Belladonna alkaloids O 115 Benzodiazepines O 740 5-Benzyloxy-2-thiocyanatomethyl-4-pyranone O 252 Berberines from Enantia O 358 Bis-thiazoles O 800 Bleomycin depot formulation O 256 BNP-166 O 142 Boeckelheide-transformation O 804 Bradykinin, - cardioprotective actions O 332 Buspirone powder O 49 Butenolids O 448 Callistemon lanceolatus O 494 Cannabinoid analogues O 108 Cantharidin R 223 Capillary electrophoresis, - hexetidine O 248 Captopril O 635 Carbamates O 791 Carboxylic esters, - hydrolysis R 87 Careya arborea O 698 Casearia esculenta O 758 Celecoxib O 619 Cell culture, - biosensor controlled O 270 Cellulose derivative, - cationic O 628 Centranthus longiflorus O 559 Cephalosporin production O 489 Cephalosporium acremonium O 489 Cetirizine O 313 Chalcones O 614 Chemical delivery systems O 94, O 130, O 135 Chiral stationary phases O 169 Chiralpak AD-RH column O 682 Chitosan, - grafted with acrylamide O 744 Chlorzoxazone O 811 Cineol type glycoside from Nepeta O 279 Ciprofloxacin, - interaction with excipients O 825 Cisapride SC 501 Clausena heptaphylla O 573 Cleavage, - dithioacetal O 453 Clenbuterol analogues SC 70 Clitocybe rivulosa SC 778 Clomiphene O 72 Clomipramine O 405 CNIBS/R-K equation SC 861 Coalescence kinetics, - fat emulsions O 54 Colour reaction, - dialkylamin drugs O 530 - napthoquinones O 456 Column chromatography, - Hypericum derivatives O 178 Consolida scleroclada O 761 Content uniformity O 49 Conversion, - microbiological O 59 Corticosteroids, - toxicity O 142 Coumarins, - from Clausena O 573 - from Exostema/Artemisia SC 351 COX-2-inhibitors O 301 Curcumin O 820, O 852 Cyanopeptide analogues O 729 Cyclo(Trp-Pro) O 638 Cyclodextrins R 94, O 130 - chemically modified R 94 - gliclazide complex O 191 - gliquidone complex O 632 - solubilization R 291 - sparfloxacin complex SC 505 - terfenadin complex SC 772 Cycloguineense A, B O 622 Cyclooxygenase inhibitors O 238 Cyclovoltammetry, - mesalazine prodrugs O 468 Cyclovoltammetry, - PETN O 460 Cytotoxicity, - NSAR O 848 DBH reagent O 45 Defibrase O 482 Dendrimer grafts O 261 Depsidon-type metabolites SC 73 Dexamethasone-CDS R 96 Dialkylamin drugs O 530 1,3-Dibromo-5,5-dimethylhydantoin O 45, O 172, O 250, O 316, O 393, O 471, O 538 2,3-Dichloro-1,4-naphthoquinone O 530, SC 648 Diclofenac prodrugs O 552 DIDS-inhibited anion exchanger O 848 Differential pulse voltammetry, - lacidipine SC 503 Differential pulse polarography, - atovaquone O 465 - levofloxacin SC 587 Digitalis cariensis O 716 6,7-Dihydrophthalides O 679 1,4-Dihydropyridines O 672 2,4-Dihydroxythiobenzanilides O 198 3,5-Dinitrobenzoic acid anhydride O 41 Dioscorea futschauensis O 570 Dipeptides, cyclic O 638 Diterpenoid, - from Consolida O 761 - from Indigofera O 714 Dithioacetalmonosulfoxide, - cleavage O 453 DNA damage, - hydrogen peroxide induced O 852 DNBA reagent O 41 Dodonea topical formulations O 320 Dodonea viscosa O 320 DPPG O 750 Dragendorff, Georg N. O 763 Drosera fluid extract O 201 Drug delivery, - transdermal O 482, O 632, O 750, O 838, O 842, SC 655 Drug design, - retrometabolic R 83, R 87, R 94, O 108, O 115, O 122, O 138 Drug release, - from Dodonea topical formulations O 320 - from hydrogels O 479 Drug targeting O 135, SC 147 Dry powder inhalers O 546 DSC, - ciprofloxacin O 825 Dudhi O 643 ECE process O 468 Electrochemistry, - mesalazine prodrugs O 468 - PETN O 460 Electroporation O 482 Electrosynthesis, - nitrones O 122 Emulsions, - fat O 54 Enalapril polymorphs SC 347 Enantia chlorantha O 358, O 409 Enantioseparation O 169, O 589 - flurbiprofen O 682 Enkephalin-CDS R 96 Epidermal growth factor delivery systems R 787 Eschscholzia californica O 176 Estradiol microspheres O 695 Estradiol-CDS R 96 Estrone derivative O 808 Eudesmol O 59 Eupatorium inulaefolium O 413 Euphorbia geniculata O 643 Exostema mexicanum SC 351 Fat emulsions O 54 Flavanol glycosides, - from Callistemon O 494 Flavanones O 614 Flavones from Scutellaria O 857 Flavonoid glycosides from Sanguisorba O 702 Flavonol glycoside from Psidium SC 859 Flow injection analysis, - amlodipine SC 500 5-Fluorouracil O 261 Flurbiprofen O 682 Fluvastatin O 817 Furanostanol glycoside from Agave O 562 Furo[3,4-b]pyridines O 672 Furostanol glycoside from Digitalis O 716 Fusarium culmorum SC 653 GABAA receptor O 857 Galactosidase, - extracellular O 176 GC/MS, - Piper constituents O 622 Gel formulations O 186 Gene delivery R 659 Geniculatoside from Euphorbia O 643 Ginkgo biloba SC 508 Glass classification O 396 Glibenclamide O 838 Gliclazide ß-cyclodextrin-hdroxypropylmethylcellulose complexes O 191 Glipizide O 838 Gliquidone O 632 Glycopyrrolate analogue O 138 Glycosides, - from Agave O 562 - from Digitalis O 716 - from Sanguisorba O 702 Growth factor, - epidermal R 787 Growth inhibition, - hepatoma cells O 753 H1-receptor agonists O 796 H1-receptor antagonists O 306 H3-receptor antagonists O 791 Hantzsch pyridine synthesis O 672, O 679 Haplopappus multifolius O 282 Hepatoma cells, - growth, redifferentiation O 265 Heptacaine homologs, - partition SC 499 Heterocyclization, - 3-hydrazino-1,2,4-triazino[5,6-b]indoles O 442 Hexahydropyrimidine derivatives O 377 Hexastylis sp. O 686 Hexetidine liquid formulation O 248 High shear mixer O 45 History of Pharmacy O 62, O 575, O 763 HPC gel O 842 HPLC, - aristolochic acids O 686 - BTMP - celecoxib O 619 - cetirizin O 313 - chlorzoxazone O 811 - flurbiprofen O 682 - mosparide O 814 - resorcin bonded columns SC 589 HPLV, - tinidazole O 535 Hydrogels O 479 2-Hydroxypropyl-ß-cyclodextrin O 130 Hydroxypropylmethyxlcellulose O 191 3a -Hydroxysteroid dehydrogenase SC 218 Hypericine O 178 Hypericine, - solubility O 543 Hypericum perforatum O 178, O 323, O 543 Hypoglycemic effects, - Casearia extract SC 753 - substituted amides SC 776 Illudane sesquiterpenes, - from Clitocybe SC 778 Immobilized artificial membrane chromatography SC 497 Incubated hen’s egg O 829 Indigofera longeracemosa O 714 Indigoferabietone O 714 Indirubin R 223 Indole carbocamides O 238 Indolocarbazoles O 194 Indomethacin gels O 186, O 690 Interaction, - ciprofloxacin/excipients O 825 - mucin/cellulose derivative O 628 - rabeprazole R 595 Iodine number O 538 Iontophoresis O 482 Iridoids from Phlomis O 646 Irisquinone A R 223 Iron limit test O 45 Ischmia, - myocardial O 332 ISMN oxime derivative SC 507 Isoflavanes from Sphaerophysa SC 75 Isopimarane diterpene from Nepeta O 279 Iyeremide A, B O 622 JR-30M O 628 Juniperus przewalski O 343 Ketoprofen prodrugs O 552 Khellin history O 62 Kirschsteiniothelia maritima O 270, SC 510 Kojic acid derivative O 252 König reaction O 250 Lacidipine SC 503 LA-ICP-MS O 396 LC-MS, - BTMP Lepenine O 761 Levofloxacin SC 587 Leycesteria formosa SC 431 Liberation, penetration, - bleomycin O 256 - defibrase O 482 - EGF R 787 - flavonoids O 320 - from liposomes R 659 - glibenclamide O 838 - gliquidone O 632 - hydrocortisone O 479 - nicardipine O 842 - prednisolone SC 147 - terfenadine SC 772 - theophylline O 744 - thiocolchicoside O 750 Lichens O 73 Ligularia macrophylla O 275 Ligumacrophyllal O 275 Limonene O 842 Lipid emulsion formulation O 741 Liposomes, - pH-sensitive R 659 Lipoxygenase inhibition O 243, O 362 Lobatin A, B O 413 Local anesthetics SC 499 Loteprednol etabonate R 83 Lunamarin C O 573 Malaria R 723, O 413 MCF-7 cells O 233 Membranes SC 497 Mesalazine prodrugs O 468 Metabolism, - metamizol O 829 Metamizol O 829 Microspheres O 256, O 695 Microwave induced synthesis O 602 Miotens O 750 Molconn-Z Software O 127 Molecular imprinted polymers O 169 Mosparide O 814 Mucin O 628 Mucoadhesive powder O 181 Muscoril O 750 Mushrooms extracts O 416 Naphthalene derivatives from Asphodelus O 286 Naphthoquinones O 456 Naphthyrididnes O 804 Naproxen prodrugs O 552 Nepeta pratii O 279 Neurolenin B O 413 Neuropogon sp. O 73 Neuropogonines A, B, C SC 73 Neutral endopeptidase inhibition O 556 Nicardipine, - skin penetration O 842 4-Nitro-1,8-naphthalimides SC 430 Nitrone compounds O 122 Norditerpenoid alkaloids from Aconitum O 427 NSAIDs O 552 NSC O 310 NTG O 489 Organic compounds, - surface area SC 652 Oridonine R 223 Oscillatory shear rheology O 181 OxadinŇ O 337 Oxidative stress R 30 Paal-Knorr synthesis O 243 Palmatine O 358 PAMAM O 261 Pamamycin analogs O 34 Parasitic diseases R 723 Partial Least Square method O 127 Particle size analysis O 546 Pechmann condensation O 108 Pegnology R 5 PEGylated systems R 5 Pentaerythrityltetranitrate O 460 Peptide synthesis, - protease catalysed O 310 Perfusion cell culture O 270 Permeability R 293 P-Glycoprotein R 102 PhAcOZ O 310 Pharmacokinetics, - celecoxib O 619 - metamizol O 829 - rabeprazole R 595 - tinidazole O 535 Pharmacology, - Agave extract O 562 - analgesics O 485 - antiasthmatics R 83 - antiparasitic drugs R 723 - antiplatelet therapies SC 863 - ascorbic acid O 265, O 753 - Aspilia extracts O 421 - bradykinin O 332 - captopril O 635 - Careya bark extract O 698 - Casearia extract O 753 - Centranthus extract O 559 - clomiphene O 72 - corticosteroids O 142, SC 147 - Drosera extract O 201 - Enantia alkaloids O 409 - Eupatorium extracts O 413 - Hypericum extract O 323 - indolocarbazoles O 194 - isosorbide-5-mononitrate oxime SC 507 - Juniperus terpenes O 343 - Leycesteria extracts SC 431 - mushrooms extracts O 416 - nitrates SC 507 - 4-nitro-1,8-naphthalimides SC 430 - NSAR O 848 - OxadinŇ O 337 - parasympathomimetics O 485 - phenylserinederivatives SC 650 - Phyllanthus extract O 855 - physalins SC 348 - polyene macrolides SC 218 - polyphenols O 852 - Polyscias extracts O 424 - propargyl thioquinolines O 151 - quercetin O 556 - ranitidine O 409 - resveratrol O 474, O 556 - Rumex patientia extract O 204, O 487 - Scutellaria extracts O 857 - selenite O 265 - substituted amides SC 776 - succinic acid acylhydrazides SC 776 - (- )-terpestacin SC 653 - thiobenzanilides SC 774 - Tribulus saponins O 491 - Voacanga alkaloids O 409 Phenanthridine alkaloids R 223 Phlomis aurea O 646 Phosphonate derivatives O 135 Photon correlation spectroscopy O 54 Phototoxicity R 30 - Anthraquinone derivatives O 399 - clomipramine O 405 Phyllanthus fraternus O 855 Physalins SC 215, SC 348 Physalis alkekengi SC 215 Piper guineense O 622 Piperine O 698 Pistia stratiotes O 212 PLA microspheres O 695 PLGA microspheres O 695 Pluronic F-127 O 186, O 690 Polar surface area calculation SC 652 Polarography, - DNBA reagent O 41 - levofloxacin SC 587 Polyamidoamine dendrimers O 261 Polyene macrolides O 218 Polyethylene glycol R 5 Polyhydroxystilbens O 474 Polymeric matrices O 744 Polymorphism SC 347 Polyscias filicifolia O 424 Poorly soluble drugs R 291 Potassium titanyloxalate SC 216 Powder mixing O 49 Powder O 181 Poly-e -caprolactone microspheres O 256 Prednisolone farnesylate SC 147 Pregnane glycoside from Digitalis O 716 Prodrugs O 552 Propargyl thioquinolines O 151, O 733 Prosapogenins from Albizia O 705 Protoberberines from Enantia O 358 Protoberberines O 409 Pseudohypericine O 178 Psidium gauijava SC 859 Pullulan complexes O 155 Pyridazinoquinolines O 362 Pyrrolidinediones O 519 Pyrroloquinolines O 243 QSAR O 127 Quercetin O 556, SC 216 Rabeprazole R 959 Radical scavengers R 30 RANTES levels SC 863 Reactive oxygen species R 30, O 474 Rebeccamycin O 194 Redifferentiation O 753 Resveratrol O 474, O 556, O 852 Retinoids O 438 Retinol palmitate O 635 Retrometabolic drug design R 83, R 87, R 94, O 108, O 115, O 122, O 138 Rheology O 181, O 186, O 628 Rhizopus stolonifer O 59 Rosenthaler reaction O 172 Rumex patientia O 204, O 487 Saccharin derivatives O 384 Sanguisorba minor O 702 Saponins, - from Dioscorea O 570 - from Tribulus O 491 Schiff bases O 377 Scutellaria baicalensis O 857 Serine derivatives SC 650 Serine protease inhibitors O 729 Serotonin receptor agonists O 355, O 515 Serotonin reuptake inhibitors O 355 Serrulata strangulata O 340 Sesquiterpene lactones, - from Aster O 567 - from Exostema/Artemisia SC 351 Sesquiterpenes, - from Ligularia O 275 - from Clitocybe SC 778 SG-1 O 138 Signal cascade mechanism O 332 Simvastatin O 817 Skin damage R 30 Skin permeability SC 655 Sleeping sickness O 358 Sodium cromoglycate history O 62 Soft drugs R 83, R 87, O 108, O 115, O 122, O 142 Solubility R 291 - curcumin O 820 - hypericin O 543 - polymorphs in mixed solvents SC 861 Solubilization, - benzodiazepines O 740 Sparfloxacin SC 505 Spectrophotometry, - fluvastatin O 817 - heptacaine homologs SC 499 - iron O 45 - pyridine derivatives O 250 - simvastatin O 817 Sphaerophysa salsula SC 75 Spirostanol saponin, - from Disocorea O 570 Square wave voltammetry, - cisapride SC 501 - lacidipine SC 503 SSRI O 355, O 515 Stability, - Aloe ointments O 834 - benzodiazepines O 740 - curcumin O 820 - indomethacin O 690 - kojic acid derivative BTMP Staurosporin O 194 Stereochemistry, - physalins SC 215 Steroid from Pistia O 212 Steroidal glycosides from Tribulus O 491 Steroids from Adenophora O 209 Stigmastane steroid from Pistia O 212 Strangusin A, B O 340 Streptomyces alboniger O 34 Sulfonulureas, - skin penetration O 838 Sulforhodamine B assay O 194 Surfactant solutions O 820 Sympatec O 546 Synthesis, - Arylisochromanes SC 346 - 4-aryl-4H-pyrane-3,5-dicarboxylic acid esters O 523 - atractyligenine chemistry O 374 - benzo[b]thiophene derivatives O 355, O 515 - benzo[f]furo[2,7]naphthyridines O 804 - bis(lactone)-annulated 4H-pyranes O 606 - bis-thiazoles O 800 - butenolides O 448 - cannabinoid analogues O 108 - clenbuterol analogues SC 70 - COX-2-inhibitors O 301 - cyanopeptide analogues O 729 - 2,4-diaryl-4H,5H-pyrano[3,2-c]benzopyran-5-ones O 233 - 6,7-dihydrophthalides O 679 - 1,3-dihydropyridines O 606 - estrone derivative O 808 - furo[2,3-c]quinolines O 159 - furo[3,4-b]pyridines O 672 - furo[3,4-c]quinolines O 159 - gylcopyrrolate analogue O 138 - H1-receptor agonists O 796 - H1-receptor antagonists O 306 - H3-receptor antagonists O 791 - hexahydropyrimidine derivatives O 377 - imidazolodinediones O 438 - indole carboxamides O 238 - indolocarbazoles O 194 - iron pullulan complexes O155 - methylamino quinazolin-4(3H)-ones O 306 - (6-methyl-2-methylsulfanyl-4-oxo-3,4-dihydro-3-pyrimidyl)acetic acid O 610 - microwave induced O 602 - nitrones O 122 - oxadiazino-[5,6-b]-indoles O 796 - pamamycin analogues O 34 - PEGylated systems R 5 - peptides O 310 - phenylserine derivatives SC 650 - 4,5-polymethylenepyrazoles O 301 - propargyl thioquinolines O 151 - pyrrolidinediones O 519 - pyrroloquinolines O 243 - [5-(4-pyrrol-1-yl-benzoyl-1H-pyrrol-2-yl)-acetic acid O 435 -retinoids O 438 - saccharin derivatives O 384 - serine protease inhibitors O 729 - serotonin receptor agonists O 355, O 515 - spiro[indole-oxiranes] O 602 - tetrahydrofuranyl amino acids O 34 - tetramic acid derivatives O 519 - thiazolidinediones O 438 - thioquinolines O 733 - thrombin inhibitors O 729 - triazines O 442 - d-tryptanthrin SC 586 - tropyl a -phenylcyclopentylacetate derivatives O 115 - phenylserine derivatives SC 650 Tartu university O 763 Terfenadine SC 772 Terpenes from Juniperus O 343 Terpenoids from Haplopappus O 282 (- )-Terpestacin SC 653 Testosterone-CDS O 135 Thalleioquine reaction O 172 Thin layer chromatography, - in enantioseparation O 169 Thiobenzanilides SC 774 Thiol active ligands SC 70 Thrombin inhibitors O 729 Timolol O 169 Tinidazole O 535 Total parenteral nutrition O 54 Toxicity, - 2,4-dihydroxythiobenzanilides O 198 Toxicity, - cyclo(Trp-Pro) isomers O 638 Traditional Chinese Medicine R 223 TRH analogues O 130 TRH-CDS O 130 Trialkylamines SC 648 Tribulus terrestris O 491 Trichosanthin R 223 Tripterpenoidal prosapogenins from Albizia O 705 Triumfetta flavescens O 709 Triumfettoside O 709 Trypanomiasis R 723 Trypanosoma brucei O 358 d-Tryptanthrin SC 586 Ulocladium sp. SC 653 Urushiols, - allergenic SC 508 UV light R 30 Vanillin O 852 Vilsmeier-Haak process O 435 Voacanga africana O 409 Willipelletierine O 761 Wojahn, Hans O 575 Wolinsky method O 523 Yersinia infections O 337
Numbers refer to the first page of the article R = Review; O = Original article; SC = Short communiation; B = Book review; S = Supplement
Abdel-Hamid, M. O 252
Issue 1: pp.
1 - 80
|
